title: Mammaglobin B expression in human endometrial cancer.
abstract: Mammaglobin B (MGB-2) is an uteroglobin gene family member recently found highly differentially expressed in ovarian cancer by gene expression profiling. To evaluate its potential as a novel endometrial cancer biomarker, in this study we quantified and compared MGB-2 expression at messenger RNA and protein levels in endometrial tumors (endometrioid endometrial cancer [EEC]) with different grades of differentiation. MGB-2 expression was evaluated by real-time polymerase chain reaction (PCR) and immunohistochemistry (IHC) in fresh frozen biopsies and paraffin-embedded tissues derived from a total of 70 patients including 50 primary EEC and 20 normal endometria (NECs). High levels of MGB-2 gene expression were detected in 10 of 11 EEC G1 cases (91%), 16 of 17 EEC G2 cases (94%), and 6 of 22 EEC G3 cases (27%) by real-time PCR. In contrast, normal endometrial cells expressed low to negligible levels of MGB-2 by real-time PCR (P = 0.002 EEC vs NEC). Well- and moderately differentiated EECs overexpressed MGB-2 gene at significant higher levels when compared to NECs (P < 0.01). Pairwise differences between both G2 and G1 vs G3 cases for MGB-2 relative gene expression values were also statistically significant (G2 vs G3 P < 0.001, G1 vs G3 P = 0.016). MGB-2 protein expression was detected in 31 (86%) of 36 EEC and 0 of 5 atrophic NEC controls, while seven of eight (88%) of the proliferative/secretory/hyperplastic NECs focally expressed MGB-2 by IHC. MGB-2 is highly expressed in EEC, particularly in well- and moderately differentiated tumors, and may represent a novel molecular marker for EEC.
authors.affiliation: Division of Gynecologic Oncology, University of Brescia, Brescia, Italy.
authors.forename: R A
authors.initials: RA
authors.lastname: Tassi
authors.forename: E
authors.initials: E
authors.lastname: Bignotti
authors.forename: M
authors.initials: M
authors.lastname: Falchetti
authors.forename: S
authors.initials: S
authors.lastname: Calza
authors.forename: A
authors.initials: A
authors.lastname: Ravaggi
authors.forename: E
authors.initials: E
authors.lastname: Rossi
authors.forename: F
authors.initials: F
authors.lastname: Martinelli
authors.forename: E
authors.initials: E
authors.lastname: Bandiera
authors.forename: S
authors.initials: S
authors.lastname: Pecorelli
authors.forename: A D
authors.initials: AD
authors.lastname: Santin
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016889:Endometrial Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006262:Health; D006801:Humans; D007150:Immunohistochemistry; D060788:Mammaglobin B; D008875:Middle Aged; D009185:Myelin Proteins / Q000235:genetics / Q000378:metabolism*; D009367:Neoplasm Staging; D011510:Proteolipids / Q000235:genetics / Q000378:metabolism*; D060765:Secretoglobins; D014598:Uteroglobin / Q000235:genetics / Q000378:metabolism*
chemical_list: D060788:Mammaglobin B; D009185:Myelin Proteins; D011510:Proteolipids; C556467:SCGB2A1 protein, human; D060765:Secretoglobins; D014598:Uteroglobin